Overview

Intravenous Administration of Magnesium Sulfate in Laparoscopic Hysterectomy Cases

Status:
Not yet recruiting
Trial end date:
2023-08-15
Target enrollment:
0
Participant gender:
Female
Summary
In our study, it was aimed to show the contribution of intraoperative intravenous magnesium sulfate administration to peroperative opioid consumption and postoperative analgesia.
Phase:
N/A
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Ondokuz Mayıs University
Treatments:
Magnesium Sulfate
Criteria
Inclusion Criteria:

- Patient undergoing abdominal hysterectomy

- Between the ages of 20-70,

- ASA I- II

Exclusion Criteria:

- Presence of hepatic and renal dysfunction,

- Presence of cardiac arrhythmia or other cardiac comorbidity,

- Neurological and psychiatric disorder,

- Chronic use of calcium and beta blockers,

- Drug or alcohol abuse,

- Pregnancy and lactation status,

- Patients with a history of allergy to any drug included in the study protocol